Therapeutic Potential of Novel Antimicrobial Peptide Pap12-6-10: Mechanisms of Antibacterial and Anti-inflammatory Action Against Gram-Negative Sepsis
Journal of Medicinal Chemistry · 09.10.2025 · 68 (19) · 20283-20303
DOI: 10.1021/acs.jmedchem.5c01360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 19.09.2025. Verfasst von Byeongkwon Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea. Hauptthemen laut MEDLINE: Sepsis, Anti-Bacterial Agents, Antimicrobial Peptides, Anti-Inflammatory Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea National Institute of Health.
Themen: Sepsis
Abstract (Originalsprache)
To develop novel antibiotics, we engineered 12-mer peptides derived from the N-terminus of papiliocin. Pap12-6-10 emerged as a potent antibacterial agent against multidrug-resistant Gram-negative bacteria, demonstrating a low propensity for resistance development. Pap12-6-10 exerts its antibacterial activity by permeabilizing bacterial membranes through binding to lipopolysaccharide (LPS), inducing oxidative stress that leads to cell death. Pap12-6-10 modulates LPS-induced inflammatory responses by selectively targeting the TLR4 signaling pathways. Structural analysis using NMR, surface plasmon resonance, docking, and molecular dynamics simulations suggested that Pap12-6-10 binds to the hydrophobic pocket of MD-2, thereby preventing the LPS-induced dimerization of the TLR4/MD-2 complex, which is essential for inflammatory signaling during sepsis. In the Escherichia coli K1 and carbapenem-resistant Acinetobacter baumannii-induced sepsis mouse model Pap12-6-10 protected organ damage from septic shock and displayed significant therapeutic effects while maintaining low cytotoxicity. This study highlights its potential as a valuable candidate for treating Gram-negative infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea.
- Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
- Biopharmaceutical Research Center, Korea Basic Science Institute, Cheongju 28119, Republic of Korea.
- Center for Bio-imaging and Translational Research, Korea Basic Science Institute, Cheongju 28119, Republic of Korea.
ORCID-Profile: Jin Kyeong Lee, Heewoong Yoon, Jiwon Seo, Yangmee Kim
Förderung
- National Research Foundation of Korea
- Korea National Institute of Health
Zitieren
APA
Kim, B., Lee, J. K., Son, M., Lee, H., Lee, C. Y., Jeong, J., Song, D., Yoon, H., Hwang, E., Jeong, M. S., Seo, J., & Kim, Y. (2025). Therapeutic Potential of Novel Antimicrobial Peptide Pap12-6-10: Mechanisms of Antibacterial and Anti-inflammatory Action Against Gram-Negative Sepsis. Journal of Medicinal Chemistry, 68(19), 20283-20303. https://doi.org/10.1021/acs.jmedchem.5c01360
Vancouver
Kim B, Lee JK, Son M, Lee H, Lee CY, Jeong J, et al. Therapeutic Potential of Novel Antimicrobial Peptide Pap12-6-10: Mechanisms of Antibacterial and Anti-inflammatory Action Against Gram-Negative Sepsis. Journal of Medicinal Chemistry. 2025;68(19):20283-20303. doi:10.1021/acs.jmedchem.5c01360
BibTeX
@article{Kim2025,
author = {Kim, Byeongkwon and Lee, Jin Kyeong and Son, Minwon and Lee, Hyeju and Lee, Chae Yeong and Jeong, Junho and Song, Dasom and Yoon, Heewoong and Hwang, Eunha and Jeong, Myeong Seon and Seo, Jiwon and Kim, Yangmee},
title = {Therapeutic Potential of Novel Antimicrobial Peptide Pap12-6-10: Mechanisms of Antibacterial and Anti-inflammatory Action Against Gram-Negative Sepsis},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {19},
pages = {20283--20303},
doi = {10.1021/acs.jmedchem.5c01360}
}
EUVIMED